Back to search

Enterprise Therapeutics Holdings Limited

12868901

active
Private Limited Company
england wales
Companies House
Health Score
70 / 100

Some Concerns

30/30
Filing
0/30
Financial
40/40
Risk
  • Going concern doubt noted in accounts (-10)

Details

SUSSEX INNOVATION CENTRE SCIENCE PARK SQUARE, FALMER, BN1 9SB
Incorporated 09/09/2020

Compliance

Last accounts

31/12/2025

group

Next accounts due

30/09/2027

On track

Confirmation statement

Last: 08/09/2025

Due 22/09/2026

On track

Industry

96090
Other personal service activities

Officers

Dr Philip James Boyd

secretary · Since 09/09/2020

Mr Bart Dzikowski

director · Since 05/10/2020

DIRECTOR

CANADIAN · SWITZERLAND · Age 50

Dr Peter Michael Finan

director · Since 05/10/2020

VENTURE INVESTOR

BRITISH · ENGLAND · Age 59

Also on 15 other boards

Dr John William Ford

director · Since 05/10/2020

CEO

BRITISH · UNITED KINGDOM · Age 52

Also on 2 other boards

Dr Alexander Volker Mayweg

director · Since 05/10/2020

VENTURE PARTNER

GERMAN · SWITZERLAND · Age 51

Mr Amit Munshi

director · Since 05/10/2020

COMPANY DIRECTOR

AMERICAN,SWISS · UNITED STATES · Age 58

Dr Johnathan Craig Richardson

director · Since 05/10/2020

INVESTMENT PARTNER

BRITISH · UNITED KINGDOM · Age 49

Also on 2 other boards

Dr Geert-Jan Mulder

director · Since 05/10/2020

INVESTMENT MANAGER

DUTCH · NETHERLANDS · Age 60

Dr Robbie Woodman

director · Since 05/01/2024

INVESTOR

BRITISH · UNITED KINGDOM · Age 48

Dr Janet Margaret Justine Hammond

director · Since 20/05/2024

DIRECTOR

AMERICAN · UNITED STATES · Age 66

Persons with Significant Control

Former PSCs

Dr Philip James Boyd

Ceased 05/10/2020

CompanyRankvs 32497+ SIC 96090 peers
51

Financial strength100th percentile among SIC peers · 25/25
Employees98th percentile among SIC peers · 15/15
LiquidityNo balance sheet data · 0/20
Longevity6 years trading (max 15) · 6/15
Filing complianceAll filings up to date · 15/15
Going concern doubt -10
Show leaderboard
How is this score calculated?
Financial strength25/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees15/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity0/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity6/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Risk deductions

Going concern doubt: -10 pts

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Going Concern Doubt

in accordance with IFRS as adopted by the UK , subject to any material departures disclosed and explained in the financial statements; ∙ assess the Group and Company 's ability to continue as a going concern, disclosing, as applicable, matters related to going concern; and ∙ use the going concern basis of accounting unless they either intend to liquidate the Group or the Company or to cease

Key FinancialsYear ending 30/06/2025

Net Worth

£5.0M

Balance sheet strength

Cash

Cash in the bank

Net Current Assets

Working capital

Current Assets

£5.1M

Current Liabilities

Profit After Tax

-£1.2M

18avg. employees

Balance Sheet

Total assets£5.1M
Prepared with Caseware UK (AP4) 2024.0.164

EstimatesDerived

YearImplied Profit
2025-£1.2M

Derived from filed accounts. Not audited figures.